Related Experiment Video

Updated: Jun 9, 2026

Creating Transient Cell Membrane Pores Using a Standard Inkjet Printer
07:07

Creating Transient Cell Membrane Pores Using a Standard Inkjet Printer

Published on: March 16, 2012

39.0K

Inkjet Printing of Pharmaceuticals

Paola Carou-Senra1, Lucía Rodríguez-Pombo1, Atheer Awad2

  • 1Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma Group (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, 15782, Spain.

Advanced Materials (Deerfield Beach, Fla.)
|November 10, 2023
PubMed
Summary

Inkjet printing (IJP) offers precise 3D and 2D fabrication for personalized medicine using specialized pharma-inks. Advancements in materials, hardware, software, and AI promise to revolutionize healthcare manufacturing for patient-specific treatments.

Keywords:
bioprintingdigital healthcare and industry 4.0drop-on-demand and continuous ink-jet additive manufacturingpersonalised medicationsprecision medicinequick response (QR) codes and data matrix patternstwo- and three-dimensional printing of pharmaceuticals using pharma-inks

More Related Videos

Inkjet-printed Polyvinyl Alcohol Multilayers05:11

Inkjet-printed Polyvinyl Alcohol Multilayers

Published on: May 11, 2017

12.7K
Inkjet Printing All Inorganic Halide Perovskite Inks for Photovoltaic Applications07:42

Inkjet Printing All Inorganic Halide Perovskite Inks for Photovoltaic Applications

Published on: January 22, 2019

11.2K

Related Concept Videos

Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...